Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1598646 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $4.79 · Day +5.51% · Mkt cap $217M · 1Y +109.1% · Off 52W high −61.6% · Vol (1Y) 171.1% Price2023-08-21 → 2026-08-19 NERV close: $9.4 on 2023-08-21 to $4.8 on 2026-08-19. Split-adj closes · 240 of 2,912 · price returnⓘ At a glance | Short interest5.1% of sh out | | Days to cover15.5d | | 13F net flow (QoQ)+8.35% | | Top-10 13F concentration78.4% | | Next report (est.)2026-11-08 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+19.2% | | 1Y+109.1% | | 3Y−48.8% | | 5Y−66.7% | | 10Y−95.4% | | Since incept. (ann.)−17.4% |
Total return · from 2014-07-01ⓘ Risk | Ann. volatility (1Y)171.1% | | Ann. volatility (3Y)122.3% | | Sharpe (1Y)0.97 | | Sharpe (3Y)0.34 | | Max drawdown (1Y)−51.4% | | Max drawdown (3Y)−89.3% | | Beta (3Y vs SPY)1.19 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| FEDERATED HERMES, INC. | 5.1M | $31M | 11.82% | −4.8% | | Vivo Capital, LLC | 4.3M | $26M | 9.99% | +0.0% | | JANUS HENDERSON GROUP PLC | 4.3M | $26M | 9.92% | +47614.0% | | Balyasny Asset Management L.P. | 4.3M | $26M | 9.84% | new | | Logos Global Management LP | 3.2M | $19M | 7.43% | −2.9% | | FARALLON CAPITAL MANAGEMENT LLC | 2.4M | $14M | 5.47% | +0.0% | | Foresite Capital Management VI LLC | 2.0M | $12M | 4.59% | new | | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $11M | 4.27% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-07 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-07 | −$0.14 | — | — | — | | 2026-03-31 | 2026-05-05 | −$2.86 | — | — | — | | 2025-09-30 | 2025-11-05 | −$0.36 | −112.1% | — | — | | 2025-06-30 | 2025-08-14 | −$0.43 | — | — | — |
As-reported XBRL · next 2026-11-08 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
